BlackRock Inc. decreased its holdings in MAXIMUS, Inc. (NYSE:MMS) by 2.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,194,340 shares of the health services provider’s stock after selling 173,234 shares during the period. BlackRock Inc. owned about 11.73% of MAXIMUS worth $492,165,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of MMS. Global Retirement Partners LLC bought a new stake in shares of MAXIMUS in the 3rd quarter worth $29,000. Signaturefd LLC increased its holdings in shares of MAXIMUS by 237.0% in the 2nd quarter. Signaturefd LLC now owns 1,112 shares of the health services provider’s stock worth $78,000 after purchasing an additional 782 shares in the last quarter. Public Employees Retirement System of Ohio bought a new stake in shares of MAXIMUS in the 2nd quarter worth $92,000. Advisor Group Holdings Inc. bought a new stake in shares of MAXIMUS in the 1st quarter worth $160,000. Finally, HighPoint Advisor Group LLC bought a new stake in shares of MAXIMUS in the 3rd quarter worth $208,000. 94.19% of the stock is owned by institutional investors and hedge funds.
In related news, CEO Bruce Caswell sold 23,303 shares of MAXIMUS stock in a transaction on Wednesday, September 30th. The stock was sold at an average price of $68.41, for a total transaction of $1,594,158.23. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Vice Chairman Richard A. Montoni sold 12,000 shares of MAXIMUS stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $73.68, for a total value of $884,160.00. The disclosure for this sale can be found here. Insiders have sold 77,122 shares of company stock worth $5,394,762 over the last quarter. 2.00% of the stock is owned by company insiders.
Shares of MMS opened at $72.31 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.95 and a quick ratio of 1.95. MAXIMUS, Inc. has a one year low of $46.42 and a one year high of $80.50. The firm has a market capitalization of $4.43 billion, a P/E ratio of 21.85 and a beta of 0.87. The business has a fifty day moving average of $69.74 and a 200 day moving average of $71.42.
MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Wednesday, November 18th. The health services provider reported $1.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.89 by $0.13. MAXIMUS had a return on equity of 17.29% and a net margin of 6.41%. Analysts expect that MAXIMUS, Inc. will post 3.27 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Thursday, November 12th. This represents a $1.12 annualized dividend and a yield of 1.55%. MAXIMUS’s dividend payout ratio (DPR) is presently 30.11%.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. It operates through three segments: U.S. Health and Human Services, U.S. Federal Services, and Outside the U.S. The U.S. Health and Human Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Featured Article: Are 12b-1 Fees Affecting Your Mutual Fund Performance?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.